Indication and Timing of Thyroid Surgery for Patients with Hereditary Medullary Thyroid Cancer Syndromes

Author： Ogilvie Jennifer B.   Kebebew Electron  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.4, Iss.2, 2006-02, pp. : 139-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vandetanib: In Medullary Thyroid Cancer

By Frampton James E.  

Drugs, Vol. 72, Iss. 10, 2012-07 ,pp. : 1423-1436

Adis International

Access to resources Recommend Favorite

Surgery for lymph node metastases of medullary thyroid carcinoma: A review

By Jin Linda X.   Moley Jeffrey F.  

Cancer, Vol. 122, Iss. 3, 2016-02 ,pp. : 358-366

Blackwell Publishing

Access to resources Recommend Favorite

18F-DOPA and 18F-FDG PET/CT, Scintigraphic Localization and Radioguided Surgery of Recurrent Medullary Thyroid Cancer: Two Case Reports

By  

Current Radiopharmaceuticals, Vol. 7, Iss. 2, 2014-12 ,pp. : 133-137

Bentham Science Publishers

Access to resources Recommend Favorite

XL184 (cabozantinib) for medullary thyroid carcinoma

By Durante Cosimo   Russo Diego   Verrienti Antonella   Filetti Sebastiano  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 407-413

Informa Healthcare

Access to resources Recommend Favorite